Dr. Houchens is the Chief of the Antibacterials Branch within the CBRN Division of BARDA and has been with BARDA since April 2012. His primary focus is building and managing a diverse portfolio of novel therapeutics targeting both biowarfare agents and the global threat of antimicrobial resistance. In this role, Dr. Houchens conducts outreach with industry to identify new partnership opportunities and participates on numerous interagency working groups across the US government with the goal of strengthening collaborations and coordinating efforts among US government agencies and stakeholders to accelerate the research, development and procurement of effective medical countermeasures.
Chris received his PhD in Cell and Molecular Biology from the University of Vermont and continued his training as a Research Fellow at Johns Hopkins Medical Institute and a Staff Scientist at Memorial Sloan-Kettering Cancer Center. Prior to joining BARDA, Chris served as a Senior Scientist at the Defense Advanced Research Projects Agency where he managed translational research and development programs to rapidly design, manufacture and evaluate novel medical countermeasures.